Scientific Program

Friday, November 17, 2023

09:00-09:10 Introduction Itamar Raz, Israel, Stefano Del Prato, Italy
09:10- 11:10 Session 1: Type 1 Diabetes: Future Technologies and Treatments
Chairs: Paolo Pozzilli, Italy, Paul Valensi, France, Gilad Twig, Israel
09:10-09:30 New treatments emerging for type1 diabetes Paolo Pozzilli, Italy
09:30-09:50 Functional interactions of glucose-lowering drugs with the cardiovascular autonomic system Paul Valensi, France
09:50-10:10 Treatment of obesity and diabetes with GLP-1 – past, present, and future Daniel Druker, Canada
10:10-10:30 Cure of T1D Domenico Accili, USA
10:30-10:50 Roundtable discussion
10:50-11:10 Coffee Break
11:10-13:10 Session 2: Present and the Future in Treatment of Diabetes
Chairs: Stefano Del Prato, Italy, Gilad Twig, Israel, Eugene Merzon, Israel
11:10-11:30 Prevention Ralph Defronzo, USA
The talk is sponsored by Ely Lilly, this is an independent sponsorship without control over the content
11:30-11:50 Cure Stefano Del Prato, Italy
11:50-12:10 New is good but old is gold Juliana Chan, Hong Kong
12:10-12:30 Small molecules potentially to prevent T1D Zachary Bloomgarden, USA
12:30-13:10 Roundtable discussion
13:10-14:10 Lunch Break
14:10-16:00 Session 3: Obesity
Chairs: Luc Van Gaal, Belgium, Nicola Napoli, Italy
14:10-14:30 Are mechanisms of weight loss equal in surgery and drugs? Nicola Napoli, Italy
14:30-14:50 Is there a future for bariatric surgery? Francesco Rubino, UK
14:50-15:10 Optimizing the Benefits of Metabolic Surgery Lee Kaplan, USA
15:10-15:30 Long-term cardiovascular effect and mortality Luc Van Gaal, Belgium
15:30-16:00 Roundtable discussion
16:00-16:10 Conclusion
Stefano Del Prato, Italy

Saturday, November 18, 2023

09:00-11:40 Session 4: Prevention / Cure of Target Organs
Chairs: Francesco Rubino, UK, Alex Miras, Ireland, Gilad Twig, Israel
09:10-09:30 Clinical strategies for the use and management of combination therapies (both medical and surgical) Napoli Nicola, Italy
09:30-09:50 Cure – Drugs/Surgery Luc Van Gaal, Belgium
09:50-10:20 Can drugs replace surgery? YesStefano Del Prato, Italy NoFrancesco Rubino, UK
10:20-10:40 Weight gains after bariatric surgery Drugs- Alex Miras, Ireland
10:40-11:00 Modular endoscopic bariatric and metabolic therapies: Best of both worlds Barham Abu Dayyeh, USA
11:00-11:20 Roundtable discussion
11:20-11:40 Coffee Break
11:40-13:10 Session 5: Diabetes and CV risk
Chairs: Eberhard Standl, Germany, Karsten Kristiansen, Denmark, Francesco Giorgino, Italy
11:40-12:00 Prevention Hypoglycemia Eberhard Standl, Germany
12:20-12:40 New pharmacologic approaches for dyslipidemia Italy Anna Solini, Italy
12:40-13:00 Microbiome Karsten Kristiansen, Denmark
13:00-13:10 Roundtable discussion
13:10-14:10 Lunch Break
14:10-16:00 Session 6: The brain, obesity, and GLP-1
Chairs: Anna Solini, Italy, Tali Cukierman-Yaffe, Israel, Banshi Saboo, Indi
14:10-14:30 Brain Health & Diabetes Tali Cukierman-Yaffe, Israel
14:30-14:50 Building on GLP-1 receptor agonism to enhance efficacy and adherence Francesco Giorgino, Italy
14:50-15:10 Perceptions, attitudes, motivators and barriers among adolescents living with obesity, caregivers and healthcare professionals in Saudi Arabia Hussein Elbadawi, Kingdom of Saudi Arabia
15:10-15:30 Impact of Glucagon-like peptide-1 (GLP-1) receptor agonists on insulin resistance and weight Merita Emini Sadiku, Kosova
15:30-15:50 Association between Gestational diabetes and immigration status: A Systematic Review and Meta-analysis Samira Behboudi Gandevani, Norway
15:50-16:00 Summary and conclusion
Francesco Rubino, Italy, Stefano del Prato, Italy

Sunday, November 19, 2023 – Virtual Program

09:00-10:50 Session 7: Prevention and treatment of target organs
09:00-09:10 Introduction Itamar Raz, Israel
09:10-09:30 SGLT2
Lambers Heerspink, Netherlands
09:30-09:50 The Kidney
Gil Chernin, Israel
Supported by Bayer
09:50-10:10 The Liver
Rifaat Safadi, Israel
10:10-10:20 The Heart
Pam Taub, USA
10:20-10:35 Artificial pancreas – Devices to prevent hypoglycemia Ram Weiss, Israel
10:35-10:50 Prevention of inflammation
Roni Weinberg Sibony, Israel
10:50-11:50 Session 8: T1D
10:50-11:10 Prevention of T1D
Jay Skyler, USA
11:10-11:25 Prevention of Immune attack on stem cell
Matthias Hebrok, USA
11:25-11:40 CGM interpretation Banshi Saboo, India
11:40-11:55 Residual Cardiovascular Risk in Type 2 Diavetes: How Long is the Journey Ahead?
Ralph DeFronzo, USA
11:55-12:50 Session 9: Longevity
11:55-12:10 Old and new approaches in the management of hyperglycemia Antonio Ceriello, Italy
12:10-12:30 Life extension
Einav Gross, Israel
12:30-12:50 Longevity
Nir Barzilai, USA
12:50-13:30 Lunch Break
13:30-14:50 Session 10: Obesity
13:30-13:50 The “weight” of weight loss
Richard Pratley, USA
13:50-14:10 Long-term effect on weight and related diseases Bariatric Surgery
Ricardo Cohen, Brazil
14:10-14:30 Adolescent Obesity, Cognition and Cardiovascular Risk at Adulthood
Gilad Twig, Israel
14:30-14:50 Obesity in the Woman’s Life Cycle
Yoel Toledano, Israel
14:50-16:30 Session 11: Obesity
14:50-15:10 Multimodal treatment for obesity and diabetes Dimitrios Pournaras, UK
15:10-15:30 Continue insulin therapy or offer bariatric surgery?
Philip Home, UK
15:30-15:50 Establishing a Population-Based Obesity Registry for Effective Obesity Management in Primary Care
Eugene Merzon, Israel
15:50-16:10 The Cardio Renal Metabolic approach should we treat to prevent
Baruch Itzhak, Israel
16:10-16:30 Summary
Stefano Del Prato, Italy, Itamar Raz, Israel